Showing 4911-4920 of 5623 results for "".
- Lilly Partners With NIH to Test Olumiant in Patients Hospitalized With COVID-19https://modernod.com/news/lilly-partners-with-nih-to-test-olumiant-in-patients-hospitalized-with-covid-19/2477574/Drug companies worldwide are testing existing medicines as potential treatments for COVID-19—plus working on new therapeutics—with few answers yet. Now, Eli Lilly is among the latest to kick off a trial through a partnership with federal health officials, according t
- Physician-Scientists Pioneer New Surgical Approach to Treat Progressive Blindnesshttps://modernod.com/news/physician-scientists-pioneer-new-surgical-approach-to-treat-progressive-blindness/2477568/Dry age-related macular degeneration (AMD) poses a significant clinical challenge. It is one of the leading causes of progressive blindness, robbing millions of people over the age of 65 of their central vision, and it often hinders patients’ abilities to read books, drive and discern the faces o
- Vazegepant, Investigational Drug Being Studied for Migraine, to Enter Phase 2 Trial for COVID-19 Treatmenthttps://modernod.com/news/vazegepant-investigational-drug-being-studied-for-migraine-to-enter-phase-2-trial-for-covid-19-treatment/2477557/The FDA has authorized initiation of a phase 2 trial of vazegepant (Biohaven, New Haven, CT) for potential treatment of COVID-19 pulmonary complications. Vazegepant is an intranasally delivered calcitonin gene-related peptide (CGRP) inhibitor antagonist in phase 3 trials for the treatment of migr
- CMS Has Doled Out Nearly $34B in Advance, Accelerated Payments to Providers to Combat COVID-19https://modernod.com/news/cms-has-doled-out-nearly-34b-in-advance-accelerated-payments-to-providers-to-combat-covid-19/2477550/The Trump administration delivered nearly $34 billion in advance and accelerated payments to providers over the past week as more and more health systems furlough worker
- Nicox Outlines Plans to Progress NCX 4251 into Phase 2b Trial Following Positive Meeting with FDAhttps://modernod.com/news/nicox-outlines-plans-to-progress-ncx-4251-into-phase-2b-trial-following-positive-meeting-with-fda/2477548/Nicox SA announced that it has held a Type C meeting with the FDA in which the data from the recently completed Danube phase 2 clinical trial of NCX 4251 was reviewed and the next NCX 4251 trial designs were discussed. Given the positive Danube phase 2 trial results in reduction of the signs and
- Icare USA Completes Merger with CenterVuehttps://modernod.com/news/icare-usa-completes-merger-with-centervue/2477549/Icare USA announced that it has completed its merger with CenterVue after the acquisition of CenterVue by Revenio Group Corporation in April 2019. Financial terms of the deal were not disclosed. In March 2020, the two corporations were consolidated under a single management team. Co
- Apply for the SBA Paycheck Protection Programhttps://modernod.com/news/apply-for-the-sba-paycheck-protection-program/2477546/The Paycheck Protection Program (PPP) is a loan designed to provide a direct incentive for small businesses to keep their workers on the payroll. SBA will forgive loans if all employees are kept on the payroll for 8 weeks and the money is used for payroll, rent, mortgage interest, or utilities.</
- AAOpt and ASCO Establish Virtual Clinical Training Program to Keep Optometry Students on Graduation Trackhttps://modernod.com/news/aaopt-and-asco-establish-virtual-clinical-training-program-to-keep-optometry-students-on-graduation-track/2477542/With COVID-19 leaving students unable to see patients in person, the American Academy of Optometry (AAO) is establishing an unprecedented virtual clinical training program to help the nation’s 1,800 4th year prospective Doctors of Optometry accumulate the 350 clinical observation hours they need
- Ortho, Eurofins Lay Out Plans for High-Throughput COVID-19 Antibody Blood Testinghttps://modernod.com/news/ortho-eurofins-lay-out-plans-for-high-throughput-covid-19-antibody-blood-testing/2477541/While most antibody blood tests, including the one officially authorized by the FDA last week, have so far focused on providing rapid results at the point-of-care—by using a small test strip and a fingerprick, like a blood sugar test—others are working to deploy high-throughput versions
- Mayo Clinic’s Jonathan Holmes, MD, Appointed UArizona Chair of Ophthalmologyhttps://modernod.com/news/mayo-clinics-jonathan-holmes-md-appointed-uarizona-chair-of-ophthalmology/2477537/Jonathan M. Holmes, MD, has been appointed chair of the University of Arizona College of Medicine – Tucson Department of Ophthalmology, effective Friday, July 31. Dr. Holmes currently serves as the Joseph E. and Rose Marie Green Professor of Visual Sciences and professor of ophthalmology a